Whitehouse Laboratories is excited to announce its participation as an exhibitor at the 2017 MD&M Minneapolis Conference. MD&M Minneapolis has helped take medical devices from concept to market by uniting cutting-edge technology, shown by vendors and service providers, with the industry’s foremost minds.
Whitehouse labs will showcase its diverse and comprehensive capabilities which are essential for medical and drug delivery device compliance. Whitehouse Laboratories continues to expand into medical and drug delivery device testing, with its additions of Chemical Characterization (E&L), Toxicology Risk Assessments (TRA), and Microbiology Testing; in concert with our established reputation for ISO 11608 syringe testing capabilities and leading edge container closure integrity testing. “This is an exciting time in the medical device industry and an exciting time at AMRI,” says John Iannone, Director of Extractables/Leachables & Impurities at AMRI Global. “With changes in the regulatory landscape surrounding Chemical Characterization (ISO 10993-18), E&L, and Risk Assessments (ISO 10993-17) being used as tools to better understand Device Biocompatibility, we have developed a focused team of world class scientists with dedicated high-end instrumentation, to work with our customers in addressing these evolving requirements.”